Quite rightly most questions submitted to the Investor Meet platform ahead of the rampfest will be about forward guidance: what is the cash position now at Skinbiotherapeutics (SBTX), what is the cash burn, what are revised FY 2026 and 2027 estimates etc. But as a non shareholder and a nerd I have different questions that I have now submitted with no expectation at all of them being answered. I have asked:
Filed under: